Therefore, we systematically reviewed the related literature in this study, applying meta-analysis to conduct a comprehensive analysis upon the relationship between the ERCC1 rs11615 polymorphism and the chemosensitivity of platinum drugs in patients with ovarian cancer. Here, ERCC1 is linked to ovarian cancer.